Wed, May 10, 2023

Yigal Nochomovitz Maintained (SNDX) at Strong Buy with Decreased Target to $31 on, May 10th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-31-on-may-10th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Yigal Nochomovitz of Citigroup, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Decreased Target from $32 to $31 on, May 10th, 2023.

Yigal has made no other calls on SNDX in the last 4 months.



There are 4 other peers that have a rating on SNDX. Out of the 4 peers that are also analyzing SNDX, 0 agree with Yigal's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Yigal


  • Edward White of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $36 on, Tuesday, May 9th, 2023
  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $36 on, Tuesday, March 7th, 2023
  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $34 on, Wednesday, March 1st, 2023
  • Bradley Canino of "Stifel" Initiated at Strong Buy and Held Target at $37 on, Tuesday, January 31st, 2023

Publication Contributing Sources